133. Sickle Cell Disease: Shifting Paradigms in Optimal Management for NPs (CE)

Sickle cell disease (SCD) is a condition of immense and multifarious clinical gravity causing acute pain, joint damage, anemia and risk of infection, stroke, delayed growth in children and adolescents — as well as long-term organ dysfunction. However, recent evolutions in treatment options offer promising novel and emerging therapeutics poised to truly revolutionize SCD care. On this episode of NP Pulse: The Voice of the Nurse Practitioner® , nurse practitioner (NP) specialists Sheryl Mitchell and Artangela Henry guide NPs to achieve the following learning objectives: Describe the epidemiologic patterns, pathophysiologic principles and robust patient burden of SCD. Examine current best practices for SCD diagnosis, highlighting the fundamental importance of early disease detection, characterization and linkage to treatment. Evaluate the established and evolving therapeutic landscape for SCD, with a focus on recent regulatory approvals and emerging trial data for novel agents. Design individualized, evidence-driven treatment plans for patients with SCD that mitigate disease complications and improve quality of life. Identify residual unmet needs in the SCD treatment paradigm and discuss the role of ongoing research and comprehensive, multidisciplinary care strategies in closing these gaps. This program and the accompanying clinical resource tool were made possible by a medical education grant from Vertex. Continuing education (CE) credit for this program may be claimed through Dec. 31, 2025. To claim credit for this program, log in to the CE Center , search for this program by name and complete the post-test and evaluation by entering the participation code that is given after listening to the podcast.